LETHAM, Scotland, Aug. 15, 2024 /PRNewswire/ — MDJM LTD (Nasdaq: MDJH) (the “Company” or “MDJM”), an integrated global culture-driven asset management company, announced today the appointment of Professor Duncan Murray Campbell to the Expert Committee of its wholly owned subsidiary, MD Local Global Limited, a United Kingdom Company. Professor Campbell’s extensive expertise in Chinese cultural […]
Category Archives: Pr Newswire
PALO ALTO, Calif., Aug. 15, 2024 /PRNewswire/ — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced financial results for its second quarter ended June 30, 2024. Operating Highlights User recharge totaled $15.8 million in the first half of 2024, with 62.0% generated from the U.S. In the first half of 2024, […]
The iconic blended Scotch whisky will become the club’s Official Whisky Partner celebrating their shared ambition for collective success ahead of the new season To celebrate the partnership, Chivas Regal and Arsenal buy a pre-match round for the local community and spirited Gooners with a Chivas Highball giveaway across local pubs LONDON, Aug. 15, 2024 /PRNewswire/ […]
PEMGARDA™ launched commercially in Q2 2024 with $2.3 million of net product revenue Notable acceleration of commercial results in early Q3 2024, with the anticipated peak fall/winter respiratory virus season approaching New commercial leadership with Chief Commercial Officer, Tim Lee, an experienced biopharmaceutical leader with demonstrated commercial success Achieved Medicare and Medicaid coverage, rapid growth […]
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that Kent Kresa has decided to retire from MannKind’s Board of Directors effective September […]
WILMETTE, Ill., Aug. 14, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced the successful dosing of the first patient in its open-label Phase 1 imaging and dosimetry clinical trial of its uPAR-targeted imaging radiopharmaceutical MNPR-101-Zr. MNPR-101-Zr was well-tolerated with no […]
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immuno-oncology therapy, today reported financial results for the three and six months ended June 30, 2024. The Company also provided an update on its clinical […]
Initiated Phase 2b trial of VYN201 in nonsegmental vitiligo, with top-line results expected in mid-2025 Phase 1a SAD/MAD trial of VYN202 progressing, with data from the SAD and MAD portions expected in Q3 and Q4 2024, respectively Balance sheet expected to fund key clinical milestones for VYN201 and VYN202 through the end of 2025 BRIDGEWATER, […]
SHANGHAI, Aug. 14, 2024 /PRNewswire/ — Four Seasons Education (Cayman) Inc. (“Four Seasons Education” or the “Company”) (NYSE: FEDU), a tourism and education-related service provider in China, today announced that its Board of Directors has declared a cash dividend of US$0.23 per ordinary share, or US$2.30 per American Depositary Share (“ADS”). The dividend is expected […]
LONDON, Aug. 14, 2024 /PRNewswire/ — Multi-asset broker Vantage Markets (“Vantage”) is proud to announce the “Reborn” phase of its “Reborn a Trader” campaign in collaboration with the NEOM McLaren Extreme E team. This latest collaboration features two exclusive interviews with NEOM McLaren Extreme E drivers, Mattias Ekström and Cristina Gutierrez, who share their personal […]
